NCT03529422 2025-07-20Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHNUNC Lineberger Comprehensive Cancer CenterPhase 2 Active not recruiting18 enrolled 10 charts
NCT03854032 2025-06-06Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and NeckThomas Jefferson UniversityPhase 2 Active not recruiting45 enrolled